Medicine and Dentistry
ACE Inhibitor
87%
Angiotensin Receptor Antagonist
87%
Biomedical Research
12%
Cohort Analysis
12%
Combination Therapy
50%
Comorbidity
12%
Decompensated Heart Failure
12%
Drug Therapy
12%
Echocardiography
12%
Ejection Fraction
50%
Follow up
25%
Hazard Ratio
37%
Heart Failure
100%
Left Ventricular Systolic Dysfunction
12%
Life Expectancy
12%
Low Drug Dose
12%
Mental Capacity
12%
Mineralocorticoid Antagonist
62%
New York Heart Association Class
12%
Patient Recruitment
25%
Recommended Drug Dose
75%
Valvular Heart Disease
12%
Nursing and Health Professions
Angiotensin Receptor Antagonist
87%
Body Mass
25%
Cause of Death
12%
Cohort Analysis
12%
Combination Therapy
50%
Comorbidity
12%
Dipeptidyl Carboxypeptidase Inhibitor
87%
Drug Dose
12%
Drug Therapy
12%
Echocardiography
12%
Follow up
25%
Heart Ejection Fraction
50%
Heart Failure
100%
Left Ventricular Systolic Dysfunction
12%
Life Expectancy
12%
Low Drug Dose
12%
Mineralocorticoid Antagonist
62%
New York Heart Association Class
12%
Outpatient Department
12%
Recommended Drug Dose
75%
Treatment Outcome
12%
Valvular Heart Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
87%
Comorbidity
12%
Dipeptidyl Carboxypeptidase Inhibitor
87%
Heart Failure
100%
Left Ventricular Systolic Dysfunction
12%
Life Expectancy
12%
Mineralocorticoid Antagonist
62%
Valvular Heart Disease
12%